InBody Co.,Ltd (041830.KQ)
KRW 21950.0
(-1.13%)
KRW 21950.0
(-1.13%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 29.41 Billion KRW | 5.56% |
| 2022 | 27.86 Billion KRW | 51.82% |
| 2021 | 18.35 Billion KRW | 12.42% |
| 2020 | 16.32 Billion KRW | -17.97% |
| 2019 | 19.9 Billion KRW | 25.59% |
| 2018 | 15.85 Billion KRW | 49.47% |
| 2017 | 10.6 Billion KRW | 14.55% |
| 2016 | 9.25 Billion KRW | 2.99% |
| 2015 | 8.98 Billion KRW | 60.59% |
| 2014 | 5.59 Billion KRW | 26.11% |
| 2013 | 4.43 Billion KRW | 6.18% |
| 2012 | 4.18 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 34.61 Billion KRW | 13.42% |
| 2024 Q1 | 30.51 Billion KRW | 3.74% |
| 2023 Q4 | 29.41 Billion KRW | -2.14% |
| 2023 FY | 29.41 Billion KRW | 5.56% |
| 2023 Q1 | 28.96 Billion KRW | 3.91% |
| 2023 Q2 | 29.02 Billion KRW | 0.23% |
| 2023 Q3 | 30.06 Billion KRW | 3.56% |
| 2022 FY | 27.86 Billion KRW | 51.82% |
| 2022 Q4 | 27.86 Billion KRW | -5.38% |
| 2022 Q3 | 29.45 Billion KRW | 9.48% |
| 2022 Q2 | 26.9 Billion KRW | 11.04% |
| 2022 Q1 | 24.22 Billion KRW | 31.97% |
| 2021 Q1 | 17.06 Billion KRW | 4.54% |
| 2021 Q3 | 19.07 Billion KRW | 5.26% |
| 2021 Q4 | 18.35 Billion KRW | -3.79% |
| 2021 Q2 | 18.12 Billion KRW | 6.19% |
| 2021 FY | 18.35 Billion KRW | 12.42% |
| 2020 Q2 | 20.71 Billion KRW | -7.34% |
| 2020 FY | 16.32 Billion KRW | -17.97% |
| 2020 Q3 | 18.19 Billion KRW | -12.17% |
| 2020 Q1 | 22.35 Billion KRW | 12.3% |
| 2020 Q4 | 16.32 Billion KRW | -10.25% |
| 2019 Q4 | 19.9 Billion KRW | -0.31% |
| 2019 FY | 19.9 Billion KRW | 25.59% |
| 2019 Q3 | 19.96 Billion KRW | 14.87% |
| 2019 Q2 | 17.38 Billion KRW | 6.11% |
| 2019 Q1 | 16.38 Billion KRW | 3.35% |
| 2018 Q1 | 14.45 Billion KRW | 36.27% |
| 2018 Q4 | 15.85 Billion KRW | -9.22% |
| 2018 FY | 15.85 Billion KRW | 49.47% |
| 2018 Q2 | 16.65 Billion KRW | 15.27% |
| 2018 Q3 | 17.46 Billion KRW | 4.82% |
| 2017 FY | 10.6 Billion KRW | 14.55% |
| 2017 Q4 | 10.6 Billion KRW | 1.7% |
| 2017 Q3 | 10.42 Billion KRW | 11.93% |
| 2017 Q1 | 9.37 Billion KRW | 1.27% |
| 2017 Q2 | 9.31 Billion KRW | -0.63% |
| 2016 Q4 | 9.25 Billion KRW | -17.51% |
| 2016 FY | 9.25 Billion KRW | 2.99% |
| 2016 Q2 | 12.28 Billion KRW | 7.9% |
| 2016 Q1 | 11.38 Billion KRW | 26.69% |
| 2016 Q3 | 11.22 Billion KRW | -8.68% |
| 2015 Q3 | 9.05 Billion KRW | 7.14% |
| 2015 Q1 | 7.7 Billion KRW | 37.68% |
| 2015 FY | 8.98 Billion KRW | 60.59% |
| 2015 Q4 | 8.98 Billion KRW | -0.75% |
| 2015 Q2 | 8.45 Billion KRW | 9.69% |
| 2014 Q3 | 6.39 Billion KRW | 3.9% |
| 2014 Q4 | 5.59 Billion KRW | -12.48% |
| 2014 Q2 | 6.15 Billion KRW | 5.07% |
| 2014 Q1 | 5.85 Billion KRW | 31.99% |
| 2014 FY | 5.59 Billion KRW | 26.11% |
| 2013 Q2 | 5.13 Billion KRW | -2.23% |
| 2013 Q4 | 4.43 Billion KRW | -13.91% |
| 2013 FY | 4.43 Billion KRW | 6.18% |
| 2013 Q1 | 5.24 Billion KRW | 25.53% |
| 2013 Q3 | 5.15 Billion KRW | 0.5% |
| 2012 Q3 | 4.19 Billion KRW | 0.0% |
| 2012 FY | 4.18 Billion KRW | 0.0% |
| 2012 Q4 | 4.18 Billion KRW | -0.46% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 15.04 Billion KRW | -95.496% |
| Curexo Inc. | 31.77 Billion KRW | 7.406% |
| Seegene, Inc. | 137.63 Billion KRW | 78.626% |
| i-SENS, Inc. | 83.54 Billion KRW | 64.786% |
| Ray Co., Ltd. | 25.37 Billion KRW | -15.95% |
| Gencurix Inc. | 581.02 Million KRW | -4963.168% |
| Sugentech Inc. | 7.01 Billion KRW | -319.084% |
| L&C Bio Co., Ltd | 46.28 Billion KRW | 36.445% |